| Literature DB >> 20531065 |
Ioannis Vrettos1, Sotiris Papageorgiou, Christina Economopoulou, Vasiliki Pappa, Panagiotis Tsirigotis, Nikolaos Tountas, Theofanis Economopoulos, John Dervenoulas.
Abstract
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20531065 DOI: 10.1097/SMJ.0b013e3181e170f5
Source DB: PubMed Journal: South Med J ISSN: 0038-4348 Impact factor: 0.954